Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2021 May 10;11:694036. doi: 10.3389/fonc.2021.694036

Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer

Frontiers Editorial Office1,*
PMCID: PMC8142891  PMID: 34041039

The journal retracts the September 2, 2020 article cited above for the following reasons:

Following publication, concerns were raised regarding manipulation in Figures 5 and 7. An investigation was conducted in accordance with Frontiers’ guidelines and the authors failed to provide a satisfactory explanation.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Editor-in-Chief of Frontiers. The authors agree to this retraction.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES